Case Finding for Coeliac Disease Using a Point of Care Test in a Pharmacy Setting

NACompletedINTERVENTIONAL
Enrollment

502

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Coeliac Disease
Interventions
DEVICE

Simtomax

Patients will undertake a finger prick point of care test, Simtomax, at the pharmacy. A sample of 25 μl of capillary venous blood is required which can be obtained through a simple finger prick technique. The sample is then applied to the test device, followed by the application of 5 drops of the provided buffer solution. The result can be read after 10 minutes. Positive results are indicated by the presence of a solid red line, with a single line for a combined IgA and IgG DGP positivity, and a single line for the presence of total IgA. An in-built control line ensures a correctly functioning test.

Trial Locations (1)

S10 2JF

Sheffield Teaching Hospitals, Sheffield

All Listed Sponsors
lead

Sheffield Teaching Hospitals NHS Foundation Trust

OTHER

NCT02675283 - Case Finding for Coeliac Disease Using a Point of Care Test in a Pharmacy Setting | Biotech Hunter | Biotech Hunter